Name | platensimycin |
---|---|
Synonyms |
Benzoic acid, 3-[[3-[(1S,3S,4S,5aS,9S,9aR)-1,4,5,8,9,9a-hexahydro-3,9-dimethyl-8-oxo-3H-1,4:3,5a-dimethano-2-benzoxepin-9-yl]-1-oxopropyl]amino]-2,4-dihydroxy-
3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxo-1,2,5,6,7,8,9,9a-octahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid Platensimycin 3-({3-[(1S,5S,6R,7S,9S,10S)-5,9-Dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1.0]tridec-2-en-5-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid |
Description | Platensimycin is an antibiotic produced by S. platensis that inhibits gram-positive bacteria by selectively inhibiting cellular lipid biosynthesis (IC50=0.1 μM). Platensimycin targets the β-ketoacyl-acyl-carrier-protein synthase I/II, FabF/B, an enzyme that participates in the biosynthesis of fatty acids (IC50s=48 nM and 160 nM for S.aureus and E.coli enzymes, respectively). Platensimycin is a promising agent for overcoming antibiotic resistance. |
---|---|
Related Catalog |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 683.1±55.0 °C at 760 mmHg |
Molecular Formula | C24H27NO7 |
Molecular Weight | 441.474 |
Flash Point | 366.9±31.5 °C |
Exact Mass | 441.178741 |
PSA | 136.65000 |
LogP | 3.00 |
Vapour Pressure | 0.0±2.2 mmHg at 25°C |
Index of Refraction | 1.670 |
RIDADR | NONH for all modes of transport |
---|